Extendicare Inc

EXE-T

TSE:EXE

5.33
0.02 (0.37%)
Extendicare Real Estate Investment Trust is a Toronto, Ontario based company that operates 440 long-term care facilities across North America. The company became a REIT and began trading on the TSX on November 10, 2006 under the symbol EXE.UN.
More at Wikipedia

Analysis and Opinions about EXE-T

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
April 28, 2020

How COVID will effect this industry, retirement homes? He owns Sienna instead. EXE is much more involved in government-funded LTCs. Along with Chartwell, these two companies are under government scrutiny, so they likely do a much better job than private LTCs. Good question how COVID will affect these homes: there may be increased costs to manage the LTCs, and he expects the government to do more oversight, particularly the incompetent LTCs. He prefers Sienna to EXE, because Sienna is a mix of LTCs and retirement homes, while Chartwell is mostly retirement homes, which has more upside but more competitive. Don't buy purely LTCs, like EXE.

Show full opinionHide full opinion
Extendicare Inc (EXE-T)
April 28, 2020

How COVID will effect this industry, retirement homes? He owns Sienna instead. EXE is much more involved in government-funded LTCs. Along with Chartwell, these two companies are under government scrutiny, so they likely do a much better job than private LTCs. Good question how COVID will affect these homes: there may be increased costs to manage the LTCs, and he expects the government to do more oversight, particularly the incompetent LTCs. He prefers Sienna to EXE, because Sienna is a mix of LTCs and retirement homes, while Chartwell is mostly retirement homes, which has more upside but more competitive. Don't buy purely LTCs, like EXE.

COMMENT
COMMENT
February 28, 2020

Extendicare has a better chart than Chartwell. It has a head-and-shoulder chart movement. If you take into account the general market sell-off, investors need to be forgiving.

Show full opinionHide full opinion
Extendicare Inc (EXE-T)
February 28, 2020

Extendicare has a better chart than Chartwell. It has a head-and-shoulder chart movement. If you take into account the general market sell-off, investors need to be forgiving.

WATCH
WATCH
February 24, 2020
He likes the aging demographics. It has been clawing itself back after problems in the US and high level debt. They are focused on their home care and supply chain businesses. They are trying to now go capital light. He is starting to look at it. It is trading at a discount, relative to peers.
Show full opinionHide full opinion
Extendicare Inc (EXE-T)
February 24, 2020
He likes the aging demographics. It has been clawing itself back after problems in the US and high level debt. They are focused on their home care and supply chain businesses. They are trying to now go capital light. He is starting to look at it. It is trading at a discount, relative to peers.
BUY
BUY
February 20, 2020
The long-term care homes are all similar. Slow growers, good dividend yielders. Payouts are reasonable. Steady stream of income. Hasn't increased dividend for 3 years. Resistant to recessions. Labour and other costs are going up. Yield around 5%.
Show full opinionHide full opinion
Extendicare Inc (EXE-T)
February 20, 2020
The long-term care homes are all similar. Slow growers, good dividend yielders. Payouts are reasonable. Steady stream of income. Hasn't increased dividend for 3 years. Resistant to recessions. Labour and other costs are going up. Yield around 5%.
HOLD
HOLD
December 23, 2019
A great demographic pick. He bought in at $7.01 in 2014 and bought in again at $6.62. He liked how they paid down debt and reduced operations in the US. He likes the dividend and thinks there is still good upside -- maybe another 50%. They have been growing organically and by takeover. He would like to see them pay down more debt. Yield 5%
Show full opinionHide full opinion
Extendicare Inc (EXE-T)
December 23, 2019
A great demographic pick. He bought in at $7.01 in 2014 and bought in again at $6.62. He liked how they paid down debt and reduced operations in the US. He likes the dividend and thinks there is still good upside -- maybe another 50%. They have been growing organically and by takeover. He would like to see them pay down more debt. Yield 5%
BUY WEAKNESS
BUY WEAKNESS
October 29, 2019
Enjoys a regulated revenue stream like other retirement homes, so it's fairly safe--but has only 2-5% growth. A long-term hold. Buy at $8, though you can sell it at $10.
Show full opinionHide full opinion
Extendicare Inc (EXE-T)
October 29, 2019
Enjoys a regulated revenue stream like other retirement homes, so it's fairly safe--but has only 2-5% growth. A long-term hold. Buy at $8, though you can sell it at $10.
DON'T BUY
DON'T BUY
October 21, 2019
Long term care. They have about 5% dividend but it is over 100% of cash flow. Sales are growing at 1.2%. The free cash flow yield is not there.
Show full opinionHide full opinion
Extendicare Inc (EXE-T)
October 21, 2019
Long term care. They have about 5% dividend but it is over 100% of cash flow. Sales are growing at 1.2%. The free cash flow yield is not there.
DON'T BUY
DON'T BUY
August 23, 2019
Would avoid right now, with government regulation risk, and bad press. There's enough risk for negative press in healthcare stock.
Show full opinionHide full opinion
Extendicare Inc (EXE-T)
August 23, 2019
Would avoid right now, with government regulation risk, and bad press. There's enough risk for negative press in healthcare stock.
BUY WEAKNESS
BUY WEAKNESS
July 31, 2019
Look at defensive stocks this time of year. EXE's moving averages are moving up. Add more at $8.60. It's overbought now, so expect consolidation first.
Show full opinionHide full opinion
Look at defensive stocks this time of year. EXE's moving averages are moving up. Add more at $8.60. It's overbought now, so expect consolidation first.
HOLD
HOLD
July 2, 2019
He bought more in December. They do have some debt -- a little higher than he likes. The payout ratio is such that the dividend is stable, but won't grow. The demographics are in their favour within senior housing. He is happy to keep holding it. Yield 5.7%
Show full opinionHide full opinion
He bought more in December. They do have some debt -- a little higher than he likes. The payout ratio is such that the dividend is stable, but won't grow. The demographics are in their favour within senior housing. He is happy to keep holding it. Yield 5.7%
BUY
BUY
April 23, 2019
The activist investor? The activist investor owns 9%. It's a leader in Canada. A great demographic play. Good dividend. This could hit $12-14. He's pleased that EXE has come to an agreement with the activist.
Show full opinionHide full opinion
Extendicare Inc (EXE-T)
April 23, 2019
The activist investor? The activist investor owns 9%. It's a leader in Canada. A great demographic play. Good dividend. This could hit $12-14. He's pleased that EXE has come to an agreement with the activist.
DON'T BUY
DON'T BUY
March 20, 2019
This sector is almost as bad as airplanes, because there are government regulations and labour issues (minimum wage) and it's labour-intensive. Also. EXE missed their numbers and hasn't done much in two years. They blew their brains out in the U.S. where they got it. Also--his theory--technological advances and government incentives encourage seniors to stay in home and not enter nursing homes. The whole sector falls shorts.
Show full opinionHide full opinion
Extendicare Inc (EXE-T)
March 20, 2019
This sector is almost as bad as airplanes, because there are government regulations and labour issues (minimum wage) and it's labour-intensive. Also. EXE missed their numbers and hasn't done much in two years. They blew their brains out in the U.S. where they got it. Also--his theory--technological advances and government incentives encourage seniors to stay in home and not enter nursing homes. The whole sector falls shorts.
BUY
BUY
February 19, 2019
He bought it years ago. Pays 4-cents each month in dividends. He's doubled-down and averaged down. It doesn't have the normal upside for him, but it's a fine demographic play. People are getting older. He sees 50-100% upside. Safe to buy more here, but he wants them to pay down its debt more.
Show full opinionHide full opinion
Extendicare Inc (EXE-T)
February 19, 2019
He bought it years ago. Pays 4-cents each month in dividends. He's doubled-down and averaged down. It doesn't have the normal upside for him, but it's a fine demographic play. People are getting older. He sees 50-100% upside. Safe to buy more here, but he wants them to pay down its debt more.
DON'T BUY
DON'T BUY
February 14, 2019
He generally likes the REITs. This one would not be the one he would pick. It is generally more volatile than he would like. The yield is a little bit stretched. SIS-T is one he would prefer slightly.
Show full opinionHide full opinion
Extendicare Inc (EXE-T)
February 14, 2019
He generally likes the REITs. This one would not be the one he would pick. It is generally more volatile than he would like. The yield is a little bit stretched. SIS-T is one he would prefer slightly.
HOLD
HOLD
February 1, 2019
Similar macro answer to Chartwell. EXE-T went to the US and it really didn't work. So now it's Ontario-centric. Not much earnings growth but a big yield. Relatively safe place to hide.
Show full opinionHide full opinion
Extendicare Inc (EXE-T)
February 1, 2019
Similar macro answer to Chartwell. EXE-T went to the US and it really didn't work. So now it's Ontario-centric. Not much earnings growth but a big yield. Relatively safe place to hide.
Showing 1 to 15 of 228 entries

Extendicare Inc(EXE-T) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 2

Neutral - Hold Signals / Votes : 1

Bearish - Sell Signals / Votes : 2

Total Signals / Votes : 5

Stockchase rating for Extendicare Inc is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Extendicare Inc(EXE-T) Frequently Asked Questions

What is Extendicare Inc stock symbol?

Extendicare Inc is a Canadian stock, trading under the symbol EXE-T on the Toronto Stock Exchange (EXE-CT). It is usually referred to as TSX:EXE or EXE-T

Is Extendicare Inc a buy or a sell?

In the last year, 5 stock analysts published opinions about EXE-T. 2 analysts recommended to BUY the stock. 2 analysts recommended to SELL the stock. The latest stock analyst recommendation is DON'T BUY. Read the latest stock experts' ratings for Extendicare Inc.

Is Extendicare Inc a good investment or a top pick?

Extendicare Inc was recommended as a Top Pick by Stephen Takacsy, B. Eng, MBA on 2020-04-28. Read the latest stock experts ratings for Extendicare Inc.

Why is Extendicare Inc stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Extendicare Inc worth watching?

5 stock analysts on Stockchase covered Extendicare Inc In the last year. It is a trending stock that is worth watching.

What is Extendicare Inc stock price?

On 2020-09-30, Extendicare Inc (EXE-T) stock closed at a price of $5.33.